Acorn Bioventures

United States
cb
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us to provide value across the entire spectrum from seed financings, cross-over financings, IPOs, registered direct offerings, PIPEs, open market purchases, etc.
Founded:2017
Firm Location:United States • New York, New York
Investor Firms That Co-Invest with Acorn Bioventures
Polaris PartnersAisling CapitalFlagship VenturesUSVPSofinnova Investments
Acorn Bioventures Team
Photo of Rakesh Ahuja, Analyst at Acorn Bioventures
Rakesh Ahuja
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Investors in BioTech
to see your intro paths to Rakesh
Photo of Anders Hove, Partner at Acorn Bioventures
Anders Hove
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in New York
Investors in BioTech, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals
to see your intro paths to Anders
ML
Max Lewin
Acorn Bioventures·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals
to see your intro paths to Max
Photo of Isaac Manke, Partner at Acorn Bioventures
Isaac Manke
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Investors in BioTech
to see your intro paths to Isaac
Photo of Gabriel Schneider, Vice President at Acorn Bioventures
Gabriel Schneider
Acorn Bioventures·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Investors in BioTech, Investors in Pharmaceuticals
to see your intro paths to Gabriel